Why Teva’s Price Target Just Got Nudged Higher Teva Pharmaceutical Industries just saw its fair value estimate move from US$32.77 to US$33.86, with the discount rate held around 8.52% and revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback